Point72 Middle East FZE’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-35,120
Closed -$2.28M 1409
2023
Q4
$2.28M Buy
35,120
+28,444
+426% +$1.71M 0.07% 363
2023
Q3
$437K Sell
6,676
-974
-13% -$61.3K 0.01% 840
2023
Q2
$445K Buy
7,650
+5,312
+227% +$335K 0.01% 811
2023
Q1
$144K Buy
2,338
+1,479
+172% +$88.7K ﹤0.01% 1027
2022
Q4
$54.6K Buy
+859
New +$62.3K ﹤0.01% 1429

Other funds holding NARI

Point72 Middle East FZE's NARI Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2024, closing a stake of 35,120 shares — an estimated $2.28M sold.

Point72 Middle East FZE first reported a position in NARI in Q4 2022 and held it in 5 quarters. The position peaked at $2.28M in Q4 2023. 231 funds tracked by Wall St. Rank hold NARI as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 35,120 Inari Medical, Inc. Common Stock shares in Q1 2024, an estimated $2.28M.
  • Point72 Middle East FZE first reported a position in Inari Medical, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • Point72 Middle East FZE's Inari Medical, Inc. Common Stock position peaked at $2.28M in Q4 2023.
  • 231 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.